Home Newsfeeds Goldman Sachs Maintains Buy on General Electric, Raises Price Target to $96

Goldman Sachs Maintains Buy on General Electric, Raises Price Target to $96

Goldman Sachs analyst Joe Ritchie maintains General Electric (NYSE:GE) with a Buy and raises the price target from $84 to $96.

byBenzinga Newsdesk

March 13, 2023

1 minute read

Goldman Sachs analyst Joe Ritchie maintains General Electric (NYSE:GE) with a Buy and raises the price target from $84 to $96.

News
SEC

Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

By Benzinga Newsdesk

November 3, 2:01 AM

Ad Hoc Announcement Pursuant to Art.53 LR Geneva, Switzerland, November 3, 2022 - Addex Therapeutics (NASDAQ:ADXN), a clinical-stage pharmaceutical company pioneering allosteric

ADXN

Analyst Ratings

Where Americold Realty Trust Stands With Analysts

By Benzinga Insights

May 8, 9:01 AM

Over the past 3 months, 4 analysts have published their opinion on Americold Realty Trust (NYSE:COLD) stock. These…

COLD

RespireRx Transferes Its Pharmaceutical Cannabinoid ProgramTo ResolutionRx

By Vuk Zdinjak

August 9, 11:12 AM

RespireRx Pharmaceuticals Inc. (OTCPK:RSPI), focused on the discovery and development of treatments to combat diseases caused by disruption of neuronal signaling, and ResolutionRx Ltd, an unlisted public Australian company, and a subsidiary of RespireRx on August 3, 2023, entered into a series of bilateral agreements intended to transfer the Re

RSPI

How Amazon Prime Video’s Ad-Supported Version Reportedly Disrupted Netflix, YouTube, And TV Networks, Forcing OTTs To Slash Prices

By Benzinga Neuro

June 14, 7:32 AM

In a significant shift in the streaming ad market, Amazon has caused a major disruption for Netflix by introducing an ad-supported version of its Prime Video service.

AMZN

Goldman Sachs Maintains Buy on General Electric, Raises Price Target to $96

Related Posts

Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Where Americold Realty Trust Stands With Analysts

RespireRx Transferes Its Pharmaceutical Cannabinoid ProgramTo ResolutionRx

How Amazon Prime Video’s Ad-Supported Version Reportedly Disrupted Netflix, YouTube, And TV Networks, Forcing OTTs To Slash Prices